`1978
`FORM pyridoxine alpha-ketoglutarate Indication prophylaxis and treatment of hyperlactatemia states, detoxifier in
`acute and chronic liver disease with hyperammonemia, an adjuvant in the treatment of hepatic encephalopathy DOS
`A 1-2 tablets 2-3 times a day, B half dose; syrup: A 3-6 teaspoons a day, B 2 teaspoons a day; vial: 1-3 vials a day
`administered intramuscularly or intravenously, by intravenous infusion up to 20 vials a day: Dosage: tablet: A 1-2
`tablets 2-3 times a day, B half dose; syrup: A 3-6 teaspoons a day, B 2 teaspoons a day; vial: 1-3 vials a day
`administered intramuscularly or intravenously, by intravenous infusion up to 20 vials a day:
`asl. (Azienda Sanitaria Locale [Local Health Office])
`023282015 30 tablets 300 mg
`
`
`
`
`
`
`
`
`
` (1500)
`5235
` B
`023282027 s 5% syrup 120 ml
`
`
`
`bottle
`
`4360
`
` B
`
`
`
`023282041 s intramuscularly or intravenously 10 vials 5ml 460mg
`
`
` box (1500)
`
`
` 6045 B
`
`ct (modalita di dispensazione [method of dispensing]) B - prescription
`
`gt (gruppo terapeutico [ therapeutic group])1206 antidotes-detoxifying
`
`s (siero [serum]) 3321 pyridoxine oxyglutarates
`
`atc (classificazione dei farmaci, Anatomica, Terapeutica, Chimica, [classification of drugs Anatomical, Therapeutic, Chemical])
` V03AB various
`sl (sublinguale [sublingual]) data sheet on the refill volume
`
`
`
`
`USPlabs EXHIBIT 1008
`
`